Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of "drug class change"
- Authors: Saitta, Carlo; Cabibbo, Giuseppe
- Publication year: 2023
- Type: Nota o commento
- OA Link: http://hdl.handle.net/10447/620205